Pharmacovigilance is a fundamental pillar in patient safety. As pharmacists, we play a crucial role in detecting and reporting suspected adverse drug reactions (ADRs). This process not only contributes to the ongoing surveillance of drug safety once marketed but also allows us to identify potential risks that may not have been detected in clinical trials.
What is Pharmacovigilance and Why is it Important?
Pharmacovigilance is defined as the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problem. Its main objective is to ensure that the benefits of medicines outweigh their risks, thereby protecting public health. The reporting of suspected ADRs by healthcare professionals, including pharmacists, is the cornerstone of this system. It enables health authorities, such as the Spanish Agency of Medicines and Medical Devices (AEMPS), to have real-time information on the safety of medicines in the general population.
Reporting a suspected ADR is an act of professional and ethical responsibility. Every report, however small it may seem, can be a key piece in identifying a safety pattern or detecting a rare but serious adverse event. The information collected helps to update drug product information, issue health alerts, and make informed decisions about their use.
The Pharmacist's Role in Pharmacovigilance
The community pharmacist is a first-contact healthcare professional, placing them in a privileged position to detect and report suspected adverse reactions. Our proximity to the patient allows us to observe effects that may not manifest during a medical consultation. Furthermore, the pharmacist possesses in-depth knowledge of medicines, their mechanisms of action, and their safety profiles, which facilitates the identification of possible causal relationships between a drug and an undesirable effect.
Active reporting by the pharmacist not only enriches the pharmacovigilance database but also strengthens patient trust in the pharmacy as a health centre. By informing the patient about the importance of reporting any unusual effects and guiding them through the reporting process, the pharmacist performs an important role in health education and patient empowerment in managing their own health.
Reporting suspected ADRs is a professional duty and a patient's right to receive safe and quality pharmaceutical care.
How to Report a Suspected ADR? The Spanish Pharmacovigilance System
In Spain, the pharmacovigilance system is coordinated by the AEMPS. The reporting of suspected ADRs is primarily done through the online application Tarjeta Amarilla (Yellow Card). This system allows healthcare professionals to report suspected cases quickly and easily.
To report, you need to access the Tarjeta Amarilla platform (available on the AEMPS website or via direct links). You will need to complete an electronic form that includes information about the patient (age, sex, weight if relevant), the suspected medicine (name, dose, route of administration, start date), the adverse reaction (detailed description, start date, severity), and the reporter (healthcare professional, contact details). It is essential to be as precise and complete as possible in describing the symptoms and the timeline of events.
In addition to the online platform, there are other reporting channels, such as paper forms that can be requested from the Regional Pharmacovigilance Centres. However, electronic reporting is the preferred method due to its speed and the immediacy of transmitting information to the national database.
Special Cases and Additional Considerations
It is important to remember that you do not need to be absolutely certain that the medicine caused the reaction to report it. Suspicion is sufficient. The aim is to gather information on potential safety signals. Pharmacovigilance professionals will assess the causal relationship.
We must pay special attention to ADRs in vulnerable populations, such as children, the elderly, pregnant women, or patients on multiple medications, as they may be at higher risk. It is also crucial to report serious, unexpected ADRs, or those that pose a public health problem. Consulting the AEMPS health alerts may be useful for staying up-to-date on detected safety issues.
Fluid communication with the prescribing doctor is also fundamental. If you suspect an ADR, you can discuss it with the doctor to confirm the suspicion and adjust the treatment if necessary. Collaboration between professionals is key to patient safety.
Looking for something else at the counter? Cross-check a whole medication list with the drug interactions checker, or browse all the clinical tools.